BK-5-MAPB

BK-5-MAPB
Identifiers
	IUPAC name 1-(1-benzofuran-5-yl)-2-(methylamino)propan-1-one;
PubChem CID	163585306;
Chemical and physical data
Formula	C12H13NO2
Molar mass	203.241 g·mol−1
3D model (JSmol)	Interactive image;
	SMILES CC(C(=O)C1=CC2=C(C=C1)OC=C2)NC;
	InChI InChI=1S/C12H13NO2/c1-8(13-2)12(14)10-3-4-11-9(7-10)5-6-15-11/h3-8,13H,1-2H3; Key:GKZGRACLZFHCFE-UHFFFAOYSA-N;

βk-5-MAPB is an entactogenic drug which is both a substituted cathinone and substituted benzofuran, being structurally related to methylone and 5-MAPB. It acts as a monoamine releaser with selectivity for serotonin and has a similar potency to MDMA.^[1]^[2]^[3]

References

^ WO 2021/252538, Baggott M, "Advantageous benzofuran compositions for mental disorders or enhancement", published 16 December 2021, assigned to Tactogen Inc.
^ WO 2023/107653, Baggott MJ, Lofthus SJ, De Leona XM, Singh A, Hudgins CJ, "Benzofuran salt morphic forms and mixtures for the treatment of mental disorders or mental enhancement", published 21 September 2023, assigned to Tactogen Inc.
^ WO 2023/107715, Baggott M, Dalziel S, "Specialized combinations for mental disorders or mental enhancement", published 15 June 2023, assigned to Tactogen Inc.

Identifiers

IUPAC name 1-(1-benzofuran-5-yl)-2-(methylamino)propan-1-one
PubChem CID	163585306
Chemical and physical data
Formula	C₁₂H₁₃NO₂
Molar mass	203.241 g·mol⁻¹
3D model (JSmol)	Interactive image
SMILES CC(C(=O)C1=CC2=C(C=C1)OC=C2)NC
InChI InChI=1S/C12H13NO2/c1-8(13-2)12(14)10-3-4-11-9(7-10)5-6-15-11/h3-8,13H,1-2H3 Key:GKZGRACLZFHCFE-UHFFFAOYSA-N